MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Rockwell Medical Company Profile (NASDAQ:RMTI)

Consensus Ratings for Rockwell Medical (NASDAQ:RMTI) (?)
Ratings Breakdown: 2 Sell Rating(s), 3 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 1.83)
Consensus Price Target: $10.60 (44.61% upside)

Analysts' Ratings History for Rockwell Medical (NASDAQ:RMTI)
Show:
DateFirmActionRatingPrice TargetActions
4/6/2016Morgan StanleyReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2016Bank of AmericaReiterated RatingNeutral$18.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/1/2016Craig HallumDowngradeBuy -> Hold$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/1/2016Stifel NicolausDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2015OppenheimerReiterated RatingOutperform$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/11/2015Brean CapitalReiterated RatingSell$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2015Summer StreetSet Price TargetPositive -> Buy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/11/2014Chardan CapitalReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2014ING GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/14/2014FBR & Co.Initiated CoverageUnderperform$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/26/2014 forward)
Earnings History for Rockwell Medical (NASDAQ:RMTI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/2/2016        
5/10/2016Q1($0.08)($0.10)$15.25 million$13.63 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/29/2016Q4$0.02($0.12)$19.98 million$14.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2015Q315($0.02)($0.05)$14.93 million$14.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q215($0.10)($0.05)$11.84 million$12.96 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q414($0.10)($0.07)$13.20 million$13.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015Q4($0.10)($0.14)$13.51 million$14.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2014Q314($0.10)($0.10)$13.40 million$13.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2014Q2($0.13)($0.08)$13.45 million$13.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/12/2014Q1($0.14)($0.20)$14.22 million$13.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2014($0.28)($0.21)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2012Q312($0.50)($0.86)$12.57 million$12.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Rockwell Medical (NASDAQ:RMTI)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.09)($0.09)($0.09)
Q2 20161($0.06)($0.06)($0.06)
Q3 20161($0.05)($0.05)($0.05)
Q4 20161($0.03)($0.03)($0.03)
(Data provided by Zacks Investment Research)
Dividend History for Rockwell Medical (NASDAQ:RMTI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Rockwell Medical (NASDAQ:RMTI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
12/4/2015Ronald D. BoydDirectorSell12,500$10.58$132,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2015Robert L ChioiniCEOBuy4,910$11.96$58,723.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2015Raymond Dennis PrattVPBuy5,000$11.54$57,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2015Robert L ChioiniCEOBuy5,090$11.51$58,585.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2012David A HagelsteinMajor ShareholderBuy7,000$8.10$56,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Rockwell Medical (NASDAQ:RMTI)
DateHeadline
06/25/16 09:52 AMRockwell Medical, Inc. (NASDAQ:RMTI) Earnings Glance and Target Price Review - Engelwood Daily
06/23/16 03:02 PMROCKWELL MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers -
06/23/16 08:50 AMRockwell Medical Inc. (RMTI) is Trading Lower on Unusual Volume for June 21 - Equities.com
06/23/16 08:50 AMRockwell Medical Inc. (RMTI) Drops 5.3% on June 21 - Equities.com
06/23/16 07:39 AMRockwell Medical Announces Appointment of Dr. Robin Smith to Board of Directors - [at noodls] - June 23, 2016 WIXOM, Mich., June 23, 2016 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney ...
06/22/16 10:53 AMRockwell Medical, Inc. (NASDAQ:RMTI) Yearly Sales Projections At $147.276 - Investor Newswire
06/21/16 05:42 PMRockwell Medical, Inc. (NasdaqGM:RMTI) Stock Momentum Hits Weakness - CML News
06/21/16 10:30 AMStrong Buy Calls Count For Rockwell Medical, Inc. (NASDAQ:RMTI) At 0 - Investor Newswire
06/20/16 02:46 PMRockwell Medical, Inc. – Value Analysis (NASDAQ:RMTI) : June 20, 2016 -
06/20/16 07:43 AMRockwell Medical, Inc. (RMTI) Analyst Price Targets For The Coming Week - Fiscal Standard
06/18/16 10:17 AMStock to Watch: Rockwell Medical Inc (NASDAQ:RMTI - iStreetWire
06/14/16 07:46 AMRockwell Medical, Inc. breached its 50 day moving average in a Bearish Manner : RMTI-US : June 14, 2016 -
06/07/16 06:24 PMROCKWELL MEDICAL INC. (NASDAQ:RMTI) Financial Condition Compared to S&P 500 - CML News
06/06/16 06:06 PMCan Rockwell Medical, Inc. (NASDAQ:RMTI) Keep Up with Analyst Expectations? - Investor Newswire
06/06/16 04:06 PMROCKWELL MEDICAL, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/04/16 09:07 AMOverview of Analyst's Recommendations: Rockwell Medical, Inc. (NASDAQ:RMTI) , Idera Pharmaceuticals, Inc ... - Street Updates
06/03/16 02:38 PMETF’s with exposure to Rockwell Medical, Inc. : June 3, 2016 -
06/02/16 09:11 AMRockwell Medical, Inc. (RMTI) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News - Rockwell Medical, Inc. (RMTI) Do Brokers Advise Buy, Sell Or Hold?Share Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Rockwell Medical, Inc. (RMTI). The latest reports which are currently in issue on Thursday 2nd of June state 0 analysts have a rating of “strong buy”, 0 analysts “buy ...Rockwell Medical Incorporated (NASDAQ:RMTI) Shorted Shares Increased By 0.5%The PostRockwell Medical, Inc. (RMTI) Updated Analyst CoverageRisers & Fallersall 4 news articles »
05/31/16 06:29 PMRockwell Medical, Inc. (NASDAQ:RMTI) Stock Update & Estimates - Stock Tick Tock - Rockwell Medical, Inc. (NASDAQ:RMTI) Stock Update & EstimatesStock Tick TockThe consensus on Wall Street is expecting Rockwell Medical, Inc. (NASDAQ:RMTI) to post earnings of $-0.12 per share when the firm next reports it's fiscal quarterly results. According to the latest information available the report will likely be issued ...and more »
05/30/16 02:43 PMRockwell Medical, Inc. (RMTI) Broker Price Targets For The Coming Week - Share Trading News - Rockwell Medical, Inc. (RMTI) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Rockwell Medical, Inc. (RMTI). The latest reports which are currently in issue on Monday 30th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...and more »
05/27/16 07:54 PMRockwell Medical, Inc. (NASDAQ:RMTI) Closes At $9.27 - Investor Newswire - Rockwell Medical, Inc. (NASDAQ:RMTI) Closes At $9.27Investor NewswireYesterday, the stock of Rockwell Medical, Inc. (NASDAQ:RMTI) closed at $9.27 after opening at $9.28 and registering high of $9.51 and low of $9.24. The last price is $-9.51 off 1-year high of $18.90 and $3.92 away from low of $5.47 during same period.and more »
05/26/16 01:02 AMBroker Roundup For Rockwell Medical, Inc. (RMTI) - Share Trading News - Broker Roundup For Rockwell Medical, Inc. (RMTI)Share Trading News05/14/2014 – Rockwell Medical, Inc. was downgraded to “sell” by analysts at TheStreet. The share price of Rockwell Medical, Inc. (RMTI) was up +2.03% during the last trading session, with a day high of 9.73. 302041 shares were traded on Rockwell ...
05/24/16 12:55 AMRockwell Medical Incorporated (NASDAQ:RMTI) Short Interest Decreased By 2.1% - Wall Street Hints and News - Rockwell Medical Incorporated (NASDAQ:RMTI) Short Interest Decreased By 2.1%Wall Street Hints and NewsThe stock decreased 3.91% or $0.38 during the last trading session, hitting $9.34. About 480,794 shares traded hands or 26.35% up from the average. Rockwell Medical Inc (NASDAQ:RMTI) has declined 30.61% since October 16, 2015 and is downtrending.and more »
05/22/16 07:39 PMBroker Outlook For The Week Ahead Rockwell Medical, Inc. (RMTI) - Share Trading News - Broker Outlook For The Week Ahead Rockwell Medical, Inc. (RMTI)Share Trading NewsRockwell Medical, Inc. (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis.
05/20/16 02:42 PMRevenue Update on Rockwell Medical Inc(NASDAQ:RMTI) - Trade Calls - Revenue Update on Rockwell Medical Inc(NASDAQ:RMTI)Trade CallsRockwell Medical Inc(NASDAQ:RMTI) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during After-hours on May 10, 2016. Company reported revenue of $13.63M. Analysts estimated a revenue of $15.25M. Earnings per ...
05/19/16 06:55 PMETF’s with exposure to Rockwell Medical, Inc. : May 19, 2016 -
05/19/16 12:04 PMROCKWELL MEDICAL, INC. Financials -
05/18/16 07:44 PMRockwell Medical, Inc. (NASDAQ:RMTI) Annual Sales Estimate At $147.276 - RealistInvestor.com - Rockwell Medical, Inc. (NASDAQ:RMTI) Annual Sales Estimate At $147.276RealistInvestor.comAverage annual sales estimate of Rockwell Medical, Inc. (NASDAQ:RMTI) is $147.276 and the median is $147.276 as anticipated by 2 analysts for the period closed 4. The lowest sales estimate is $93.18 and the highest sales estimate is $201.373.
05/17/16 02:55 PMRockwell Medical, Inc. :RMTI-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/17/16 02:41 PMAfter Last Week What Do Analysts Think Of Rockwell Medical, Inc. (RMTI) - Share Trading News - After Last Week What Do Analysts Think Of Rockwell Medical, Inc. (RMTI)Share Trading News05/14/2014 – Rockwell Medical, Inc. was downgraded to “sell” by analysts at TheStreet. The share price of Rockwell Medical, Inc. (RMTI) was up +3.87% during the last trading session, with a day high of 8.89. 272038 shares were traded on Rockwell ...and more »
05/13/16 04:12 PMROCKWELL MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex -
05/13/16 01:06 AMRockwell Medical Inc. (RMTI) Jumps 15.44% on May 11 - Equities.com - Rockwell Medical Inc. (RMTI) Jumps 15.44% on May 11Equities.comRockwell Medical Inc. (RMTI) was among the biggest gainers on the Russell 2000 for Wednesday May 11 as the stock popped 15.44% to $8.45, representing a gain of $1.13 per share. Some 706,649 shares traded hands on 3,300 trades, compared with an ...
05/12/16 02:53 PMStock Update (NASDAQ:RMTI): Rockwell Medical Inc Reports First Quarter Results - Smarter Analyst - NewsWay 21Stock Update (NASDAQ:RMTI): Rockwell Medical Inc Reports First Quarter ResultsSmarter AnalystRockwell Medical Inc (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary ...Rockwell Medical (RMTI) Is Strong On High Volume TodayTheStreet.comRockwell Medical Inc (RMTI) Announces Earnings Results, Misses Estimates By $0.02 EPSNewsWay 21Rockwell Medical, Inc. (RMTI) Updated Broker RatingsRisers & FallersMarket Digest -B.O.D.Y Confidentialall 13 news articles »
05/12/16 02:53 PMStock Update (NASDAQ:RMTI): Rockwell Medical Inc Announces Multiple International Trademark Approvals for Triferic - Smarter Analyst - share market updates (press release)Stock Update (NASDAQ:RMTI): Rockwell Medical Inc Announces Multiple International Trademark Approvals for TrifericSmarter AnalystRockwell Medical Inc (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary ...HC Stocks To Observe: Rockwell Medical Inc (RMTI), Halozyme Therapeutics Inc. (HALO), TrovaGene Inc (TROV)share market updates (press release)Rockwell Medical Receives Multiple International Trademark Approvals for Triferic; Shares Flat Pre Bell (NASDAQ:RMTI)Sonoran Weekly ReviewRockwell Medical, Inc. (NASDAQ:RMTI): Earnings and Recommendation ReviewFranklin IndependentGlobeNewswire (press release)all 5 news articles »
05/12/16 07:17 AMRockwell Medical Announces Multiple International Trademark Approvals for Triferic® - [at noodls] - May 12, 2016 Company Strengthens Trademark Protection for Innovative Iron Replacement Drug WIXOM, Mich., May 12, 2016 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical ...
05/11/16 08:01 PMExpected For Rockwell Medical, Inc. (NASDAQ:RMTI) Sales Of $147.615 - RealistInvestor.com - Expected For Rockwell Medical, Inc. (NASDAQ:RMTI) Sales Of $147.615RealistInvestor.comAnnual sales estimate mean of Rockwell Medical, Inc. (NASDAQ:RMTI) is $147.615 and the median is $147.615 as anticipated by 2 analysts for the period ended 4. The highest sales estimate is $202.45 and lowest sales estimate is $92.78. The standard ...and more »
05/11/16 08:01 PMRockwell Medical (RMTI) Is Strong On High Volume Today - TheStreet.com - NewsWay 21Rockwell Medical (RMTI) Is Strong On High Volume TodayTheStreet.comThe gross profit margin for ROCKWELL MEDICAL INC is rather low; currently it is at 16.06%. It has decreased from the same quarter the previous year. Along with this, the net profit margin of -40.82% is significantly below that of the industry average.Rockwell Medical Inc (RMTI) Announces Earnings Results, Misses Estimates By $0.02 EPSNewsWay 21Rockwell Medical, Inc. (RMTI) Updated Broker RatingsRisers & FallersStock Update (NASDAQ:RMTI): Rockwell Medical Inc Reports First Quarter ResultsSmarter AnalystMarket Digest -B.O.D.Y Confidentialall 13 news articles »
05/11/16 02:52 PMRockwell Medical (RMTI) Is Strong On High Volume Today - See the FREE profile for RMTI NOW at Trade-Ideas More details on RMTI: Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. It offers products and services for the treatment of end-stage renal ...
05/10/16 05:17 PMEdited Transcript of RMTI earnings conference call or presentation 10-May-16 8:30pm GMT -
05/10/16 04:46 PMROCKWELL MEDICAL, INC. Files SEC form 10-Q, Quarterly Report -
05/10/16 04:44 PMRockwell Medical reports 1Q loss -
05/10/16 03:08 PMRockwell Medical Reports First Quarter Results - [at noodls] - May 10, 2016 WIXOM, Mich., May 10, 2016 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney ...
05/10/16 06:07 AMQ1 2016 Rockwell Medical Inc Earnings Release - After Market Close -
05/09/16 07:23 AMRockwell Medical, Inc. breached its 50 day moving average in a Bearish Manner : RMTI-US : May 9, 2016 -
05/06/16 01:07 AMRockwell Medical Schedules First Quarter 2016 Earnings Call - GlobeNewswire (press release) - Rockwell Medical Schedules First Quarter 2016 Earnings CallGlobeNewswire (press release)WIXOM, Mich., May 05, 2016 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services ...
05/06/16 01:07 AMRockwell Medical Inc. (RMTI) is Trading Lower on Unusual Volume for May 04 - Equities.com - Rockwell Medical Inc. (RMTI) is Trading Lower on Unusual Volume for May 04Equities.comRockwell Medical Inc. (RMTI) experienced unusually high volume on May. 04, as the stock lost 14.64% to a closing price of $7.64. The stock saw 731,047 shares trade hands over the course of the day on 3,399 trades. Given that the stock's average daily ...and more »
05/06/16 01:07 AMRobbins Arroyo LLP: Rockwell Medical, Inc. (RMTI) Misled Shareholders According to a Recently Filed Class Action - Business Wire (press release) - StockhouseRobbins Arroyo LLP: Rockwell Medical, Inc. (RMTI) Misled Shareholders According to a Recently Filed Class ActionBusiness Wire (press release)SAN DIEGO & WIXOM, Mich.--(BUSINESS WIRE)--Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against Rockwell Medical, Inc. (NASDAQGM: RMTI) in the U.S. District Court for the Southern District of New ...Stock Update (NASDAQ:RMTI): Rockwell Medical Inc Provides Update on Preparations for Calcitriol Commercial LaunchSmarter AnalystRockwell Medical Provides Update on Preparations for Calcitriol Commercial LaunchGlobeNewswire (press release)Top Earnings to Watch for: Rockwell Medical, Inc. (NASDAQ:RMTI)Street RegisterFranklin Independent -Web Breaking News -Sonoran Weekly Reviewall 11 news articles »
05/05/16 08:02 PMCNAT Rises On Trial Data, WMGI Boosts Forecast, RMTI Pays Price For Launch Delay - NVAX closed Wednesday's trading at $4.78, down 4.97%. Shares of Rockwell Medical Inc. ( RMTI) plunged more than 14% on Wednesday after the company said that it will be able to launch its low-cost generic active vitamin D drug Calcitriol only in the third ...
05/05/16 08:02 PMRockwell Medical (RMTI): Today's Weak On High Volume Stock - See the FREE profile for RMTI NOW at Trade-Ideas More details on RMTI: Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. It offers products and services for the treatment of end-stage renal ...
05/05/16 02:54 PMRobbins Arroyo LLP: Rockwell Medical, Inc. (RMTI) Misled Shareholders According to a Recently Filed Class Action - Stockhouse - StockhouseRobbins Arroyo LLP: Rockwell Medical, Inc. (RMTI) Misled Shareholders According to a Recently Filed Class ActionStockhouseShareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against Rockwell Medical, Inc. (NASDAQGM: RMTI) in the U.S. District Court for the Southern District of New York. The plaintiff brings the complaint on ...Stock Update (NASDAQ:RMTI): Rockwell Medical Inc Provides Update on Preparations for Calcitriol Commercial LaunchSmarter AnalystTop Earnings to Watch for: Rockwell Medical, Inc. (NASDAQ:RMTI)Street RegisterRockwell Medical Provides Update on Preparations for Calcitriol Commercial LaunchGlobeNewswire (press release)Franklin Independent -Web Breaking News -Sonoran Weekly Reviewall 10 news articles »
About Rockwell Medical

Rockwell Medical logoRockwell Medical, Inc. (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its lead branded drug, Triferic is indicated for iron maintenance. Triferic is an iron compound that is delivered to hemodialysis patients through dialysate, replacing the iron loss that occurs during their dialysis treatment. Its generic drug, Calcitriol, is indicated for treating secondary hyperparathyroidism in dialysis patients. It manufactures, sells, delivers and distributes hemodialysis concentrates, along with a range of ancillary products.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: RMTI
  • CUSIP: 77437410
Key Metrics:
  • Previous Close: $7.33
  • 50 Day Moving Average: $8.66
  • 200 Day Moving Average: $8.12
  • P/E Ratio: N/A
  • P/E Growth: -1.38
  • Market Cap: $377.69M
  • Current Quarter EPS Consensus Estimate: $-0.27 EPS
Additional Links:
Rockwell Medical (NASDAQ:RMTI) Chart for Sunday, June, 26, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha